Table 1.

Distribution of Proposed Instrument, Treatment, and Outcome for Patients Seen at Primary-Care Practices in the United Kingdom, 2000–2010^a

No. of Patients	Prior Treated Patient's Statin Class	Patient's Statin Class	12-Month Risk of Diabetes
			No. of Cases	%
239,092	Lipophilic	Neither lipophilic nor hydrophilicb	2,780	1.16
12,155	Lipophilic	Lipophilic	213	1.75
456	Lipophilic	Hydrophilic	7	1.54
14,125	Hydrophilic	Neither lipophilic nor hydrophilicb	167	1.18
508	Hydrophilic	Lipophilic	11	2.17
402	Hydrophilic	Hydrophilic	14	3.48

^aStudy population was based on analyses of the Health Improvement Network database presented by Danaei et al. (13).

^bEither no statin (n = 253,187) or polydrug therapy (n = 30).